Selway Asset Management’s Pfizer PFE Stock Holding History

Selway Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-400	Closed	-$18K	–	126
2022 Q3	$18K	Buy	+400	New	+$19.4K	0.01%	118

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Selway Asset Management's PFE Position: Q4 2022 in Review

Selway Asset Management sold out of Pfizer (PFE) in Q4 2022, closing a stake of 400 shares — an estimated $18K sold.

Selway Asset Management first reported a position in PFE in Q3 2022 and held it in 1 quarter. The position peaked at $18K in Q3 2022. 3,266 funds tracked by Wall St. Rank hold PFE as of Q4 2022.

Selway Asset Management reported no remaining Pfizer position as of Q4 2022 after selling out during the quarter.
Selway Asset Management sold 400 Pfizer shares in Q4 2022, an estimated $18K.
Selway Asset Management first reported a position in Pfizer in Q3 2022 and held it in 1 quarter.
Selway Asset Management's Pfizer position peaked at $18K in Q3 2022.
3,266 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.

Based on Selway Asset Management's 13F filing for Q4 2022, filed 17 Feb 2023.